人乳头瘤病毒相关头颈癌的疫苗策略
Vaccine Strategies for Human Papillomavirus-Associated Head and Neck Cancers.
作者信息
Zhou Jade Z, Jou Jessica, Cohen Ezra
机构信息
Division of Hematology and Oncology, School of Medicine, University of California, San Diego, CA 92037, USA.
Division of Gynecologic Oncology, Moores Cancer Center, University of California, San Diego, CA 92037, USA.
出版信息
Cancers (Basel). 2021 Dec 22;14(1):33. doi: 10.3390/cancers14010033.
Abstract
The rising incidence of oropharyngeal squamous cell cancers (OPSCC) in the United States is largely attributed to HPV. Prophylactic HPV vaccines have demonstrated effectiveness against oral infection of HPV 16 and HPV 18. We review the global epidemiology and biology of HPV-related cancers as well as the development of HPV vaccines and their use worldwide. We also review the various strategies and challenges in development of therapeutic HPV vaccines.
摘要
美国口咽鳞状细胞癌（OPSCC）发病率的上升在很大程度上归因于人乳头瘤病毒（HPV）。预防性HPV疫苗已证明对HPV 16和HPV 18的口腔感染有效。我们综述了HPV相关癌症的全球流行病学和生物学，以及HPV疫苗的研发及其在全球的应用。我们还综述了治疗性HPV疫苗研发中的各种策略和挑战。
相似文献
1
Vaccine Strategies for Human Papillomavirus-Associated Head and Neck Cancers.
Cancers (Basel). 2021 Dec 22;14(1):33. doi: 10.3390/cancers14010033.
2
Human Papillomavirus and Oropharyngeal Cancer.
Dent Clin North Am. 2018 Jan;62(1):111-120. doi: 10.1016/j.cden.2017.08.008. Epub 2017 Oct 7.
3
The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: implications for dentistry.
J Am Dent Assoc. 2011 Aug;142(8):915-24. doi: 10.14219/jada.archive.2011.0298.
4
Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States.
Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1660-1667. doi: 10.1158/1055-9965.EPI-19-0038. Epub 2019 Jul 29.
5
Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer.
Cancers (Basel). 2023 Mar 24;15(7):1959. doi: 10.3390/cancers15071959.
6
Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.
Presse Med. 2014 Dec;43(12 Pt 2):e429-34. doi: 10.1016/j.lpm.2014.08.010. Epub 2014 Nov 11.
7
Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
Cancer. 2016 May 15;122(10):1544-51. doi: 10.1002/cncr.29976. Epub 2016 Mar 17.
8
The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Cancer. 2016 Aug 1;122(15):2313-23. doi: 10.1002/cncr.29992. Epub 2016 May 6.
9
Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer.
Viruses. 2015 Sep 17;7(9):5040-65. doi: 10.3390/v7092860.
10
A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.
Viruses. 2019 Oct 9;11(10):922. doi: 10.3390/v11100922.
引用本文的文献
1
A new era of cancer immunotherapy: vaccines and miRNAs.
Cancer Immunol Immunother. 2025 Apr 1;74(5):163. doi: 10.1007/s00262-025-04011-5.
2
Intraperitoneal delivery of cannabidiol (CBD) and Δ-tetrahydocannabinol (THC) promotes papillomavirus infections in athymic nude mice.
Tumour Virus Res. 2024 Dec 16;19:200307. doi: 10.1016/j.tvr.2024.200307.
3
Salivary biomarkers: a promising approach for predicting immunotherapy response in head and neck cancers.
Clin Transl Oncol. 2025 May;27(5):1887-1920. doi: 10.1007/s12094-024-03742-8. Epub 2024 Oct 8.
4
Incremental net benefit of extending human papillomavirus vaccine to boys in oropharyngeal cancer burden: Meta-analysis of cost-effectiveness studies.
J Dent Sci. 2024 Oct;19(4):2045-2056. doi: 10.1016/j.jds.2024.05.032. Epub 2024 Jun 8.
5
The Role of Oncogenic Viruses in Head and Neck Cancers: Epidemiology, Pathogenesis, and Advancements in Detection Methods.
Microorganisms. 2024 Jul 19;12(7):1482. doi: 10.3390/microorganisms12071482.
6
Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting.
J Gynecol Oncol. 2024 Nov;35(6):e85. doi: 10.3802/jgo.2024.35.e85. Epub 2024 Apr 18.
7
Prevalence and risk factors of oral human papillomavirus infection among 4212 healthy adults in Hebei, China.
BMC Infect Dis. 2023 Nov 8;23(1):773. doi: 10.1186/s12879-023-08759-y.
8
Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer.
Pharmaceuticals (Basel). 2023 Sep 29;16(10):1384. doi: 10.3390/ph16101384.
9
Oral-genital HPV infection transmission, concordance of HPV genotypes and genital lesions among spouses/ partners of patients diagnosed with HPV-related head and neck squamous cell carcinoma (HNSCC): a scoping review.
Infect Agent Cancer. 2023 Oct 19;18(1):63. doi: 10.1186/s13027-023-00539-2.
10
Membrane-Active Peptides and Their Potential Biomedical Application.
Pharmaceutics. 2023 Aug 6;15(8):2091. doi: 10.3390/pharmaceutics15082091.
本文引用的文献
1
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity.
Nat Commun. 2021 Aug 31;12(1):5195. doi: 10.1038/s41467-021-25506-6.
2
HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019.
Prev Med. 2021 Mar;144:106399. doi: 10.1016/j.ypmed.2020.106399. Epub 2020 Dec 31.
3
Human Papillomavirus Vaccines: An Updated Review.
Vaccines (Basel). 2020 Jul 16;8(3):391. doi: 10.3390/vaccines8030391.
4
Lessons learned from the INHANCE consortium: An overview of recent results on head and neck cancer.
Oral Dis. 2021 Jan;27(1):73-93. doi: 10.1111/odi.13502. Epub 2020 Jul 16.
5
Alterations of HPV-Related Biomarkers after Prophylactic HPV Vaccination. A Prospective Pilot Observational Study in Greek Women.
Cancers (Basel). 2020 May 5;12(5):1164. doi: 10.3390/cancers12051164.
6
Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: Umbrella review of systematic reviews.
J Am Dent Assoc. 2020 Apr;151(4):245-254.e24. doi: 10.1016/j.adaj.2019.10.010. Epub 2020 Jan 23.
7
Human papillomavirus as a driver of head and neck cancers.
Br J Cancer. 2020 Feb;122(3):306-314. doi: 10.1038/s41416-019-0602-7. Epub 2019 Nov 11.
8
A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.
Viruses. 2019 Oct 9;11(10):922. doi: 10.3390/v11100922.
9
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
Lancet. 2019 Aug 10;394(10197):497-509. doi: 10.1016/S0140-6736(19)30298-3. Epub 2019 Jun 26.
10
Disparities and reverse disparities in HPV vaccination: A systematic review and meta-analysis.
Prev Med. 2019 Jun;123:197-203. doi: 10.1016/j.ypmed.2019.03.037. Epub 2019 Mar 29.
Zotero 插件